CRH Medical (CRHM) Downgraded by Zacks Investment Research
Zacks Investment Research downgraded shares of CRH Medical (NYSEAMERICAN:CRHM) from a hold rating to a sell rating in a research report released on Tuesday morning.
According to Zacks, “CRH Medical Corporation offers products and services to physicians for the treatment of gastrointestinal diseases primarily in the United States. The company provides the CRH O’Regan System, a single use, disposable and hemorrhoid banding technology for treating hemorrhoid grades I – IV. It distributes the CRH O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians. The company utilizes Web-based platform to connect doctors with patients as well as educating its install base of physicians. It also offers anesthesia services. CRH Medical Corporation is headquartered in Vancouver, Canada. “
Separately, TheStreet raised CRH Medical from a c rating to a b- rating in a research report on Friday, August 24th.
A number of institutional investors have recently bought and sold shares of the business. Ativo Capital Management LLC boosted its position in CRH Medical by 7.1% during the 3rd quarter. Ativo Capital Management LLC now owns 300,079 shares of the company’s stock valued at $1,185,000 after acquiring an additional 20,002 shares in the last quarter. ClariVest Asset Management LLC bought a new stake in CRH Medical during the 3rd quarter valued at approximately $154,000. Acadian Asset Management LLC bought a new stake in CRH Medical during the 3rd quarter valued at approximately $354,000. Wedge Capital Management L L P NC bought a new stake in CRH Medical during the 3rd quarter valued at approximately $373,000. Finally, Renaissance Technologies LLC boosted its position in CRH Medical by 46.0% during the 2nd quarter. Renaissance Technologies LLC now owns 383,600 shares of the company’s stock valued at $1,189,000 after acquiring an additional 120,800 shares in the last quarter.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Recommended Story: Call Option
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.